Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis
OPEN Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 30 Aug 2020
T Fiolet, A Guihur, M Rebeaud, M Mulot, N Peiffer-Smadja and Y Mahamat-Saleh
Hydroxychloroquine or chloroquine with or without azithromycin have been widely promoted to treat COVID-19 following early in vitro antiviral effects against SARS-CoV-2 OBJECTIVE: The aim of this systematic review and meta-analysis was to assess whether chloroquine or hydroxychloroquine with or without azithromycin decreased COVID-19 mortality compared to the standard of care.
* Data courtesy of Altmetric.com